全球化妝品安全監測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

化妝品安全監測市場預計將從 2025 年的 159.6 億美元成長到 2034 年的 255.6 億美元，2026 年至 2034 年的複合年成長率為 5.37%。

隨著監管機構和生產商越來越重視化妝品安全監測，全球化妝品安全監測市場的重要性日益凸顯。化妝品安全監測包括收集、分析和評估與化妝品使用相關的不利事件資訊。這個過程有助於確保化妝品對消費者安全，並符合監管標準。

多種因素正在推動化妝品安全監測市場的成長。消費者對產品安全的日益關注以及化妝品使用的增加，促使企業實施監控系統。許多地區的監管機構要求製造商追蹤並報告不利事件，這進一步增加了對專業監測服務的需求。

隨著全球化妝品產業的持續擴張，化妝品安全監測市場前景依然強勁。數位化報告系統和數據分析技術可望提升產品安全監測和評估水準。隨著消費者對透明度和安全性的要求日益提高，化妝品安全監測將在維護行業標準方面發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球化妝品安全監測市場：依階段類型分類

• 市場分析、洞察與預測
• 臨床前
• 第一階段
• 第二階段
• 第三階段
• 第四階段

第5章 全球化妝品安全監測市場：依服務類型分類

• 市場分析、洞察與預測
• 上市前（臨床安全測試、文件編制、風險管理）
• 上市後（病例登記、病例分診、資料輸入/收集、追蹤和報告）

第6章：全球化妝品安全監測市場：依類別分類

• 市場分析、洞察與預測
• 護膚
• 化妝品
• 護髮
• 香水和除臭劑

第7章 全球化妝品安全監測市場：依服務供應商分類

• 市場分析、洞察與預測
• 內部結構
• 合約外包（合約研究組織 (CRO)、業務流程外包組織 (BPO)）

第8章 全球化妝品安全監測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AxeRegel
  • PharSafer
  • AB Cube
  • Aixial Group
  • Di Renzo
  • Accenture
  • OC Vigilance
  • SKILLPHARMA SRL
  • Proclinical

The Cosmetovigilance Market size is expected to reach USD 25.56 Billion in 2034 from USD 15.96 Billion (2025) growing at a CAGR of 5.37% during 2026-2034.

The global cosmetovigilance market has gained importance as regulatory authorities and manufacturers focus on monitoring the safety of cosmetic products. Cosmetovigilance involves collecting, analyzing, and evaluating information about adverse effects related to cosmetic usage. This process helps ensure that cosmetic products remain safe for consumers and comply with regulatory standards.

Several factors are driving the growth of the cosmetovigilance market. Increasing consumer awareness about product safety and rising use of cosmetic products have encouraged companies to implement monitoring systems. Regulatory authorities in many regions require manufacturers to track and report adverse reactions, which has increased demand for specialized monitoring services.

The future outlook for the cosmetovigilance market remains strong as the cosmetics industry continues expanding globally. Digital reporting systems and data analytics technologies may improve the monitoring and evaluation of product safety. As consumers demand transparency and safer products, cosmetovigilance will play a crucial role in maintaining industry standards.

MARKET SEGMENTATION

By Phase Type

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Services Type

• Pre-marketing (Clinical Safety Testing, Document Writing, Risk Management)
• Post-marketing (Case Intake, Case Triage, Data Entry and Acquisition, Tracking and Reporting)

By Category

• Skincare
• Makeup
• Haircare
• Perfume and Deodorants

By Service Provider

• In-house
• Contract Outsourcing (Contract Research Organizations (CROs), Business Process Outsourcing Organizations (BPOs))

COMPANIES PROFILED

• AxeRegel, PharSafer, AB Cube, Aixial Group, Di Renzo, Accenture, OC Vigilance, SKILLPHARMA SRL, Proclinical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COSMETOVIGILANCE MARKET: BY PHASE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Phase Type
• 4.2. Pre-clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COSMETOVIGILANCE MARKET: BY SERVICES TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Services Type
• 5.2. Pre-marketing (Clinical Safety Testing, Document Writing, Risk Management) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Post-marketing (Case Intake, Case Triage, Data Entry and Acquisition, Tracking and Reporting) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COSMETOVIGILANCE MARKET: BY CATEGORY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Category
• 6.2. Skincare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Makeup Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Haircare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Perfume and Deodorants Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COSMETOVIGILANCE MARKET: BY SERVICE PROVIDER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Service Provider
• 7.2. In-house Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Outsourcing (Contract Research Organizations (CROs), Business Process Outsourcing Organizations (BPOs)) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COSMETOVIGILANCE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Phase Type
  • 8.2.2 By Services Type
  • 8.2.3 By Category
  • 8.2.4 By Service Provider
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Phase Type
  • 8.3.2 By Services Type
  • 8.3.3 By Category
  • 8.3.4 By Service Provider
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Phase Type
  • 8.4.2 By Services Type
  • 8.4.3 By Category
  • 8.4.4 By Service Provider
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Phase Type
  • 8.5.2 By Services Type
  • 8.5.3 By Category
  • 8.5.4 By Service Provider
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Phase Type
  • 8.6.2 By Services Type
  • 8.6.3 By Category
  • 8.6.4 By Service Provider
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COSMETOVIGILANCE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AxeRegel
  • 10.2.2 PharSafer
  • 10.2.3 AB Cube
  • 10.2.4 Aixial Group
  • 10.2.5 Di Renzo
  • 10.2.6 Accenture
  • 10.2.7 OC Vigilance
  • 10.2.8 SKILLPHARMA S.R.L
  • 10.2.9 Proclinical